Rationale for a Trial of Low-Dose Aspirin for the Primary Prevention of Major Adverse Cardiovascular Events and Vascular Dementia in the Elderly
- 1 January 2003
- journal article
- clinical trial
- Published by Springer Science and Business Media LLC in Drugs & Aging
- Vol. 20 (12), 897-903
- https://doi.org/10.2165/00002512-200320120-00004
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- A Randomized Trial of Aspirin to Prevent Colorectal AdenomasThe New England Journal of Medicine, 2003
- AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 UpdateCirculation, 2002
- Incidence of serious upper gastrointestinal bleeding/perforation in the general population:: Review of epidemiologic studiesJournal of Clinical Epidemiology, 2002
- Vascular DementiaStroke, 2000
- Inhibition of NF-κB by Sodium Salicylate and AspirinScience, 1994
- Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.Stroke, 1993
- Final Report on the Aspirin Component of the Ongoing Physicians' Health StudyThe New England Journal of Medicine, 1989
- Randomised trial of prophylactic daily aspirin in British male doctorsBMJ, 1988
- Planning the duration of a comparative clinical trial with loss to follow-up and a period of continued observationJournal of Chronic Diseases, 1981
- Assessment of Older People: Self-Maintaining and Instrumental Activities of Daily LivingThe Gerontologist, 1969